ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

FHTX vs HURA // OPERATING MARGIN

Foghorn Therapeutics Inc. (NASDAQ) VS. TuHURA Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: FHTX 2 — HURA 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FHTX VS. HURA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC FHTX HURA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -21.10% — TIE /fcf-yield <GO>
Operating Margin ACTIVE -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) 36.80% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 1/9 +2.00 FHTX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 30.4 47.5 -17.10 HURA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $123.5M $123.0M $529.1K FHTX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR FHTX REV HURA REV FHTX GROSS % HURA GROSS % FHTX FCF HURA FCF
FY 2025 $30.9M $11.5M — — -$86.1M -$27.7M
FY 2024 $22.6M $8.4M — — -$101.3M -$14.8M
FY 2023 $34.2M $67.5M — — -$118.1M -$12.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FHTX // BETA —
HURA // BETA —